Exploratory Trial of NP039 for Thoracic Aortic Replacement

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2022240022

Enrollment

Registered

2024-09-11

Start date

2024-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with vascular anastomoses that may not achieve hemostasis by ligation or normal surgical pr

Interventions

The anastomosis will be reinforced with the investigational device NP039 or the control device by random assignment and the examinations and observations specified in the protocol will be performed.

Eligibility

Inclusion criteria

Inclusion criteria: -Written informed consent from patients or legal representative if patients lack of ability to consent. -Over 18 years of age at the time of acquiring consent. , etc.

Exclusion criteria

Exclusion criteria: 1. emergency surgery patients 2. patients undergoing revision surgery on the same incision site 3. poorly controlled diabetic patients 4. immunocompromised patients 5. patients with severe drug allergy ,etc.

Design outcomes

Primary

Measure	Time frame
Reinforcement success rate per case	—

Countries

Japan, none

Contacts

Public ContactNozomi Nishibata

NIPRO CORPORATION

nishibata-nozomi@nipro.co.jp+81-77-564-9467

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026